Exceptional Response to Olaparib and Pembrolizumab for Pancreatic Adenocarcinoma With Germline <i>BRCA1</i> Mutation and High Tumor Mutation Burden: Case Report and Literature Review-Reference-Cited by-同舟云学术

Exceptional Response to Olaparib and Pembrolizumab for Pancreatic Adenocarcinoma With Germline BRCA1 Mutation and High Tumor Mutation Burden: Case Report and Literature Review

Published:2022-05 Issue:6 Volume: Page:
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precision Oncology

Author:

Lundy Joanne¹²³⁴^ORCID,McKay Owen⁵^ORCID,Croagh Daniel¹²³,Ganju Vinod⁴⁶

Affiliation:

1. Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia

2. Department of Molecular Translational Science, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia

3. Department of Surgery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia

4. Peninsula and Southeast Oncology, Frankston, Victoria, Australia

5. Department of Gastroenterology and Hepatology, Monash Health, Clayton, Victoria, Australia

6. Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.21.00437

Reference41 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Population-based analysis of treatment of pancreatic cancer and Whipple resection: Department of Defense hospitals, 1989–1994

3. Metastatic Pancreatic Cancer: ASCO Guideline Update

4. Cancer Statistics, 2021

5. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the Genetic Landscape of Pancreatic Ductal Adenocarcinoma to Support Personalized Medicine: A Systematic Review;Cancers;2023-12-21

2. Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genomic Depiction;Cancers;2023-12-19

3. Maintenance Treatment for Metastatic Pancreatic Cancer: Balancing Therapeutic Intensity with Tolerable Toxicity;Cancers;2023-07-18

4. New Treatment Options in Metastatic Pancreatic Cancer;Cancers;2023-04-17

5. Immunotherapy in Pancreatic Cancer;Pancreatic Cancer;2023